184 related articles for article (PubMed ID: 37505762)
1. Ferroptosis Mediated Novel Drug Design Approach in the Treatment of Oral Squamous Cell Carcinoma.
S D; Ramani P; Doble M; Ramasubramanian A
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2321-2327. PubMed ID: 37505762
[TBL] [Abstract][Full Text] [Related]
2. FTO Sensitizes Oral Squamous Cell Carcinoma to Ferroptosis via Suppressing ACSL3 and GPX4.
Wang Z; Li H; Cai H; Liang J; Jiang Y; Song F; Hou C; Hou J
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003537
[TBL] [Abstract][Full Text] [Related]
3. Nrf2/HO-1 Alleviates Disulfiram/Copper-Induced Ferroptosis in Oral Squamous Cell Carcinoma.
Zhao Y; Zhu S
Biochem Genet; 2024 Feb; 62(1):144-155. PubMed ID: 37286868
[TBL] [Abstract][Full Text] [Related]
4. Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2/HO-1 potentiates cisplatin responsiveness in OSCC cells.
Han L; Li L; Wu G
Mol Cell Probes; 2022 Aug; 64():101821. PubMed ID: 35490795
[TBL] [Abstract][Full Text] [Related]
5. Hyperbaric oxygen enhances X-ray induced ferroptosis in oral squamous cell carcinoma cells.
Liu J; An W; Zhao Q; Liu Z; Jiang Y; Li H; Wang D
Oral Dis; 2024 Mar; 30(2):116-127. PubMed ID: 36495316
[TBL] [Abstract][Full Text] [Related]
6. Melatonin and erastin emerge synergistic anti-tumor effects on oral squamous cell carcinoma by inducing apoptosis, ferroptosis, and inhibiting autophagy through promoting ROS.
Wang L; Wang C; Li X; Tao Z; Zhu W; Su Y; Choi WS
Cell Mol Biol Lett; 2023 May; 28(1):36. PubMed ID: 37131152
[TBL] [Abstract][Full Text] [Related]
7. System X
Li FJ; Long HZ; Zhou ZW; Luo HY; Xu SG; Gao LC
Front Pharmacol; 2022; 13():910292. PubMed ID: 36105219
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
9.
Sharif Siam MK; Sarker A; Sayeem MMS
J Biomol Struct Dyn; 2021 Oct; 39(17):6467-6479. PubMed ID: 32746771
[TBL] [Abstract][Full Text] [Related]
10. Hsa-miR-26a-5p improves OSCC sensitivity to ferroptosis by inhibiting SLC7A11.
Liang B; Wu Y
Arch Oral Biol; 2023 Dec; 156():105807. PubMed ID: 37776596
[TBL] [Abstract][Full Text] [Related]
11. CDH4 inhibits ferroptosis in oral squamous cell carcinoma cells.
Xie J; Lan T; Zheng DL; Ding LC; Lu YG
BMC Oral Health; 2023 May; 23(1):329. PubMed ID: 37237299
[TBL] [Abstract][Full Text] [Related]
12. Combination RSL3 Treatment Sensitizes Ferroptosis- and EGFR-Inhibition-Resistant HNSCCs to Cetuximab.
Liu S; Yan S; Zhu J; Lu R; Kang C; Tang K; Zeng J; Ding M; Guo Z; Lai X; Jiang Y; Wu S; Zhou L; Sun L; Zhou ZW
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012290
[TBL] [Abstract][Full Text] [Related]
13. MiR-34c-3p upregulates erastin-induced ferroptosis to inhibit proliferation in oral squamous cell carcinomas by targeting SLC7A11.
Sun K; Ren W; Li S; Zheng J; Huang Y; Zhi K; Gao L
Pathol Res Pract; 2022 Mar; 231():153778. PubMed ID: 35093695
[TBL] [Abstract][Full Text] [Related]
14. ZC3H13 reduced DUOX1-mediated ferroptosis in laryngeal squamous cell carcinoma cells through m6A-dependent modification.
Huang L; Chen G; He J; Wang P
Tissue Cell; 2023 Oct; 84():102187. PubMed ID: 37536262
[TBL] [Abstract][Full Text] [Related]
15. Personalized Targeted Therapeutic Strategies against Oral Squamous Cell Carcinoma. An Evidence-Based Review of Literature.
Cao M; Shi E; Wang H; Mao L; Wu Q; Li X; Liang Y; Yang X; Wang Y; Li C
Int J Nanomedicine; 2022; 17():4293-4306. PubMed ID: 36134201
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Ferroptosis and Application to Head and Neck Squamous Cell Carcinoma Treatments.
Li S; Liu Y; Li J; Zhao X; Yu D
DNA Cell Biol; 2021 Jun; 40(6):720-732. PubMed ID: 33979530
[TBL] [Abstract][Full Text] [Related]
17. Advances in the study of regulators of ferroptosis in head and neck squamous cell carcinoma (Review).
Yang M; Guo R; Chen X; Song G; Zhang F
Int J Mol Med; 2023 Jun; 51(6):. PubMed ID: 37052257
[TBL] [Abstract][Full Text] [Related]
18. Eugenol Inhibits the Biological Activities of an Oral Squamous Cell Carcinoma Cell Line SCC9
Duan Y; Huang X; Qiao B; Ma R; Li J
Anticancer Agents Med Chem; 2022 Aug; 22(15):2799-2806. PubMed ID: 35331101
[TBL] [Abstract][Full Text] [Related]
19. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
[TBL] [Abstract][Full Text] [Related]
20. Multi-omics Analysis of Ferroptosis Regulation Patterns and Characterization of Tumor Microenvironment in Patients with Oral Squamous Cell Carcinoma.
Gu W; Kim M; Wang L; Yang Z; Nakajima T; Tsushima Y
Int J Biol Sci; 2021; 17(13):3476-3492. PubMed ID: 34512160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
